[8-K] Solventum Corporation Reports Material Event
Solventum Corporation filed a Form 8-K reporting a securities offering process. The filing lists an Underwriting Agreement dated August 13, 2025 among Solventum, Goldman Sachs & Co. LLC, BofA Securities, Inc. and 3M Company, a legal opinion and consent from Cleary Gottlieb Steen & Hamilton LLP, and a press release announcing pricing of the offering of the Shares dated August 13, 2025. The report identifies the companys common stock as NYSE-listed. The filing does not include details in the body of this submission about the number of shares, price per share, gross proceeds, or use of proceeds; those details may be contained in the referenced exhibits.
Solventum Corporation ha depositato un Modulo 8-K relativo a un processo di offerta di titoli. Il deposito indica un Contratto di Sottoscrizione datato 13 agosto 2025 tra Solventum, Goldman Sachs & Co. LLC, BofA Securities, Inc. e 3M Company, un parere legale e il consenso di Cleary Gottlieb Steen & Hamilton LLP, e un comunicato stampa che annuncia il prezzo dell'offerta delle Azioni datato 13 agosto 2025. Nel rapporto viene indicato che le azioni ordinarie della societ脿 sono quotate al NYSE. Il documento non riporta nel corpo della comunicazione dettagli sul numero di azioni, sul prezzo per azione, sui proventi lordi o sull'utilizzo dei proventi; tali informazioni potrebbero essere contenute negli allegati citati.
Solventum Corporation present贸 un Formulario 8-K informando sobre un proceso de oferta de valores. La presentaci贸n enumera un Acuerdo de Suscripci贸n con fecha 13 de agosto de 2025 entre Solventum, Goldman Sachs & Co. LLC, BofA Securities, Inc. y 3M Company, una opini贸n legal y consentimiento de Cleary Gottlieb Steen & Hamilton LLP, y un comunicado de prensa que anuncia la fijaci贸n del precio de la oferta de las Acciones con fecha 13 de agosto de 2025. El informe identifica las acciones ordinarias de la compa帽铆a como cotizadas en la NYSE. La presentaci贸n no incluye en el cuerpo del documento detalles sobre el n煤mero de acciones, precio por acci贸n, ingresos brutos o uso de los ingresos; esos detalles pueden figurar en los anexos referenciados.
靻旊菠韸鸽熂 旖旐嵓霠堨澊靺�(Solventum Corporation)鞚� 歃濌秾瓿惦 鞝堨皑鞕� 甏�霠暣 Form 8-K毳� 鞝滌稖頄堨姷雼堧嫟. 鞝滌稖 靹滊鞐愲姅 靻旊菠韸鸽熂, 瓿摐毵岇偔鞀�&旖� LLC, BofA 鞁滍亹毽嫲歃�, Inc., 3M 旎错嵓雼� 臧勳潣 2025雲� 8鞗� 13鞚� 鞛� 鞚胳垬瓿勳暯, Cleary Gottlieb Steen & Hamilton LLP鞚� 氩曤瓴暣 氚� 霃欖潣靹�, 攴鸽Μ瓿� 2025雲� 8鞗� 13鞚� 鞛� 欤检嫕 瓿惦 臧�瓴� 瓿奠嫓 氤措弰鞛愲臧� 旮办灛霅橃柎 鞛堨姷雼堧嫟. 氤搓碃靹滊姅 須岇偓鞚� 氤错喌欤缄皜 NYSE鞐� 靸侅灔霅橃柎 鞛堨潓鞚� 氚濏瀳瓿� 鞛堨姷雼堧嫟. 氤� 鞝滌稖靹滌潣 氤鸽鞐愲姅 欤检嫕 靾�, 欤茧嫻 臧�瓴�, 齑� 靾橃澋 霕愲姅 靾橃澋 靷毄觳橃棎 甏�頃� 靸侅劯 雮挫毄鞚� 韽暔霅橃柎 鞛堨 鞎婌溂氅�, 頃措嫻 鞝曤炒電� 彀胳“霅� 鞝勳嫓氍�(觳秬靹滊)鞐� 韽暔霅橃柎 鞛堨潉 靾� 鞛堨姷雼堧嫟.
Solventum Corporation a d茅pos茅 un formulaire 8-K signalant une proc茅dure d'offre de titres. Le d茅p么t mentionne un accord de souscription dat茅 du 13 ao没t 2025 entre Solventum, Goldman Sachs & Co. LLC, BofA Securities, Inc. et 3M Company, un avis juridique et le consentement de Cleary Gottlieb Steen & Hamilton LLP, ainsi qu'un communiqu茅 de presse annon莽ant la tarification de l'offre des Actions dat茅 du 13 ao没t 2025. Le rapport indique que les actions ordinaires de la soci茅t茅 sont cot茅es au NYSE. Le d茅p么t ne contient pas dans le corps du document de d茅tails sur le nombre d'actions, le prix par action, le produit brut ou l'utilisation des produits聽; ces informations peuvent figurer dans les annexes r茅f茅renc茅es.
Die Solventum Corporation hat ein Formular 8-K eingereicht, in dem ein Wertpapierangebotsverfahren gemeldet wird. Die Einreichung nennt ein Zeichnungsabkommen vom 13. August 2025 zwischen Solventum, Goldman Sachs & Co. LLC, BofA Securities, Inc. und 3M Company, ein rechtliches Gutachten und die Zustimmung von Cleary Gottlieb Steen & Hamilton LLP sowie eine Pressemitteilung zur Preisfestsetzung des Angebots der Aktien vom 13. August 2025. Im Bericht wird die Stammaktie des Unternehmens als an der NYSE notiert ausgewiesen. Im Text dieser Einreichung sind keine Angaben zur Anzahl der Aktien, zum Preis je Aktie, zu den Bruttoerl枚sen oder zur Verwendung der Erl枚se enthalten; diese Details k枚nnten in den genannten Anlagen stehen.
- Underwriting agreement executed dated August 13, 2025, indicating the offering process reached formal execution
- Counsel opinion and consent from Cleary Gottlieb Steen & Hamilton LLP included as exhibits
- Press release announcing pricing of the offering is attached as an exhibit, indicating the offering was priced
- Key offering economics are not disclosed in the 8-K text: number of shares, price per share, and gross proceeds are not stated
- Use of proceeds and potential dilution effects are not described in the filing text and must be obtained from the exhibits
Insights
TL;DR: The filing documents a priced equity offering with standard underwriting and counsel opinions, but the 8-K text lacks offering economics.
The exhibits cited鈥攗nderwriting agreement, counsel opinion and consent, and a pricing press release鈥攁re typical for a registered offering closing or pricing announcement. Legal counsel involvement and a formal underwriting agreement indicate the issuer followed customary transactional steps. The 8-K text itself omits the offering size, price, and allocation details; those are presumably in the attached underwriting agreement and press release, which investors and counsel should review for material terms, indemnities, underwriting discounts, and lock-up provisions.
TL;DR: This is a routine disclosure of a priced share offering; the filing confirms placement agents and pricing occurred on August 13, 2025.
The named underwriters are major investment banks, which is consistent with a marketed equity transaction. The presence of a priced press release suggests the offering was executed rather than only announced. The 8-K does not provide proceeds, share count, or pricing metrics in the filing text, so assessment of dilution or capital impact requires examining the exhibits referenced.
Solventum Corporation ha depositato un Modulo 8-K relativo a un processo di offerta di titoli. Il deposito indica un Contratto di Sottoscrizione datato 13 agosto 2025 tra Solventum, Goldman Sachs & Co. LLC, BofA Securities, Inc. e 3M Company, un parere legale e il consenso di Cleary Gottlieb Steen & Hamilton LLP, e un comunicato stampa che annuncia il prezzo dell'offerta delle Azioni datato 13 agosto 2025. Nel rapporto viene indicato che le azioni ordinarie della societ脿 sono quotate al NYSE. Il documento non riporta nel corpo della comunicazione dettagli sul numero di azioni, sul prezzo per azione, sui proventi lordi o sull'utilizzo dei proventi; tali informazioni potrebbero essere contenute negli allegati citati.
Solventum Corporation present贸 un Formulario 8-K informando sobre un proceso de oferta de valores. La presentaci贸n enumera un Acuerdo de Suscripci贸n con fecha 13 de agosto de 2025 entre Solventum, Goldman Sachs & Co. LLC, BofA Securities, Inc. y 3M Company, una opini贸n legal y consentimiento de Cleary Gottlieb Steen & Hamilton LLP, y un comunicado de prensa que anuncia la fijaci贸n del precio de la oferta de las Acciones con fecha 13 de agosto de 2025. El informe identifica las acciones ordinarias de la compa帽铆a como cotizadas en la NYSE. La presentaci贸n no incluye en el cuerpo del documento detalles sobre el n煤mero de acciones, precio por acci贸n, ingresos brutos o uso de los ingresos; esos detalles pueden figurar en los anexos referenciados.
靻旊菠韸鸽熂 旖旐嵓霠堨澊靺�(Solventum Corporation)鞚� 歃濌秾瓿惦 鞝堨皑鞕� 甏�霠暣 Form 8-K毳� 鞝滌稖頄堨姷雼堧嫟. 鞝滌稖 靹滊鞐愲姅 靻旊菠韸鸽熂, 瓿摐毵岇偔鞀�&旖� LLC, BofA 鞁滍亹毽嫲歃�, Inc., 3M 旎错嵓雼� 臧勳潣 2025雲� 8鞗� 13鞚� 鞛� 鞚胳垬瓿勳暯, Cleary Gottlieb Steen & Hamilton LLP鞚� 氩曤瓴暣 氚� 霃欖潣靹�, 攴鸽Μ瓿� 2025雲� 8鞗� 13鞚� 鞛� 欤检嫕 瓿惦 臧�瓴� 瓿奠嫓 氤措弰鞛愲臧� 旮办灛霅橃柎 鞛堨姷雼堧嫟. 氤搓碃靹滊姅 須岇偓鞚� 氤错喌欤缄皜 NYSE鞐� 靸侅灔霅橃柎 鞛堨潓鞚� 氚濏瀳瓿� 鞛堨姷雼堧嫟. 氤� 鞝滌稖靹滌潣 氤鸽鞐愲姅 欤检嫕 靾�, 欤茧嫻 臧�瓴�, 齑� 靾橃澋 霕愲姅 靾橃澋 靷毄觳橃棎 甏�頃� 靸侅劯 雮挫毄鞚� 韽暔霅橃柎 鞛堨 鞎婌溂氅�, 頃措嫻 鞝曤炒電� 彀胳“霅� 鞝勳嫓氍�(觳秬靹滊)鞐� 韽暔霅橃柎 鞛堨潉 靾� 鞛堨姷雼堧嫟.
Solventum Corporation a d茅pos茅 un formulaire 8-K signalant une proc茅dure d'offre de titres. Le d茅p么t mentionne un accord de souscription dat茅 du 13 ao没t 2025 entre Solventum, Goldman Sachs & Co. LLC, BofA Securities, Inc. et 3M Company, un avis juridique et le consentement de Cleary Gottlieb Steen & Hamilton LLP, ainsi qu'un communiqu茅 de presse annon莽ant la tarification de l'offre des Actions dat茅 du 13 ao没t 2025. Le rapport indique que les actions ordinaires de la soci茅t茅 sont cot茅es au NYSE. Le d茅p么t ne contient pas dans le corps du document de d茅tails sur le nombre d'actions, le prix par action, le produit brut ou l'utilisation des produits聽; ces informations peuvent figurer dans les annexes r茅f茅renc茅es.
Die Solventum Corporation hat ein Formular 8-K eingereicht, in dem ein Wertpapierangebotsverfahren gemeldet wird. Die Einreichung nennt ein Zeichnungsabkommen vom 13. August 2025 zwischen Solventum, Goldman Sachs & Co. LLC, BofA Securities, Inc. und 3M Company, ein rechtliches Gutachten und die Zustimmung von Cleary Gottlieb Steen & Hamilton LLP sowie eine Pressemitteilung zur Preisfestsetzung des Angebots der Aktien vom 13. August 2025. Im Bericht wird die Stammaktie des Unternehmens als an der NYSE notiert ausgewiesen. Im Text dieser Einreichung sind keine Angaben zur Anzahl der Aktien, zum Preis je Aktie, zu den Bruttoerl枚sen oder zur Verwendung der Erl枚se enthalten; diese Details k枚nnten in den genannten Anlagen stehen.
FAQ
What did Solventum (SOLV) report in the August 13, 2025 Form 8-K?
Who are the underwriters named in the 8-K for SOLV?
Does the 8-K disclose how many shares SOLV is offering or the price?
Is there legal counsel opinion included with SOLV's filing?
Where can I find the detailed terms of the offering referenced in the 8-K?
